Organization
Hospital de Sierrallana, Rheumatology, Torrelavega, Spain
3 abstracts
Abstract
ANTI-HMGCR AUTOANTIBODY LEVELS IN THE FOLLOW-UP OF STATIN-INDUCED IMMUNE-MEDIATED NECROTIZING MYOPATHY. MULTICENTRIC STUDY OF 24 PATIENTSOrg: Hospital de Sierrallana, Rheumatology, Torrelavega, Spain, Hospital Universitario Marqués de Valdecilla, Rheumatology, Santander, Spain, National Institute of Geriatrics, Rheumatology and Rehabilitation, Rheumatology, Warsaw, Poland, Medical University of Warsaw, Neurology, Warsaw, Poland, Department of Medicine, Karolinska Institute, Rheumatology, Stockholm, Sweden,
Abstract
BIOLOGICAL THERAPY IN REFRACTORY NEUROBEHÇET’S DISEASE. MULTICENTER STUDY OF 42 PATIENTSOrg: Hospital Universitario Marqués de Valdecilla, Rheumatology, Santander, Spain, Hospital de Sierrallana, Rheumatology, Torrelavega, Spain, Hospital Universitario La Princesa, Rheumatology, Madrid, Spain, Hospital Universitario de Donostia, Rheumatology and Ophtalmology, San Sebastián, Spain, Hospital 12 de Octubre, Rheumatology, Madrid, Spain,
Abstract
ARE ANTIMALARIALS SAFE FOR THE HEART OF PATIENTS WITH SYSTEMIC LUPUS ERYTHEMATOSUS? ANALYSIS OF FACTORS ASSOCIATED WITH THE DEVELOPMENT OF HEART FAILURE IN PATIENTS IN THE SPANISH SOCIETY OF RHEUMATOLOGY LUPUS REGISTRY (RELESSER)Org: Hospital de Gran Canaria Doctor Negrin, Rheumatology, Las Palmas GC, Spain, Hospital de Gran Canaria Doctor Negrin, Cardiology, Las Palmas GC, Spain, Hospital Gregorio Marañón, Rheumatology, Madrid, Spain, natalia.perez.veiga@gmail.com, Statistics, Las Palmas GC, Spain, Hospital Doce de Octubre, Rheumatology, Madrid, Spain,